Antipsychotic Agents: Clinical Trials

2 trials for Antipsychotic Agents, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 recruiting. 2 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 42Completed 1, Recruiting 1

Follow Antipsychotic Agents: new trials by email Literature Review of Antipsychotic Agents trials Research Report on Antipsychotic Agents

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
"Extended" (Alternate Day) Antipsychotic Dosing
Risperidone, Olanzapine, paliperidone - Schizophrenia and Related Disorders, Drug Administration Schedule
Phase 4RecruitingCentre for Addiction and Mental Health1202022-06-062026-04-13
Adjunctive Use of Fute (Flupentixol) in Multi-acting Receptor-targeted Antipsychotics Treated Schizophrenia Patients
Flupentixol, Multi-acting receptor-targeted antipsychotics (MARTAs) - Schizophrenia; Psychosis, Metabolic Syndrome
Phase 4CompletedTaichung Veterans General Hospital302019-12-192021-05-24

Narrower conditions

Schizophrenia (2)  ·  Central Nervous System Diseases (1)  ·  Metabolic Syndrome (1)  ·  Psychotic Disorders (1)

Broader conditions

Mental Disorders (2)  ·  Schizophrenia Spectrum and Other Psychotic Disorders (2)  ·  Glucose Metabolism Disorders (1)  ·  Hyperinsulinism (1)  ·  Insulin Resistance (1)  ·  Metabolic Diseases (1)  ·  Nervous System Diseases (1)  ·  Nutritional and Metabolic Diseases (1)

Interventions

Flupenthixol (1)  ·  Olanzapine (1)  ·  Paliperidone Palmitate (1)  ·  Risperidone (1)

Sponsors

Centre for Addiction and Mental Health (1)  ·  Taichung Veterans General Hospital (1)

Countries

Canada (1)  ·  Taiwan (1)

Top investigators

Chia-Jui Tsai, M.D. (1)  ·  Gary J Remington, MD, PhD (1)